These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 21610153)
41. MTOR inhibition attenuates DNA damage and apoptosis through autophagy-mediated suppression of CREB1. Wang Y; Hu Z; Liu Z; Chen R; Peng H; Guo J; Chen X; Zhang H Autophagy; 2013 Dec; 9(12):2069-86. PubMed ID: 24189100 [TBL] [Abstract][Full Text] [Related]
42. Targeting the JNK signaling pathway potentiates the antiproliferative efficacy of rapamycin in LS174T colon cancer cells. Benoit M; Dormond-Meuwly A; Demartines N; Dormond O J Surg Res; 2011 May; 167(2):e193-8. PubMed ID: 21324487 [TBL] [Abstract][Full Text] [Related]
43. Evaluation of the effects of the flavonoid apigenin on apoptotic pathway gene expression on the colon cancer cell line (HT29). Turktekin M; Konac E; Onen HI; Alp E; Yilmaz A; Menevse S J Med Food; 2011 Oct; 14(10):1107-17. PubMed ID: 21548803 [TBL] [Abstract][Full Text] [Related]
44. Paeonol induces cytoprotective autophagy via blocking the Akt/mTOR pathway in ovarian cancer cells. Gao L; Wang Z; Lu D; Huang J; Liu J; Hong L Cell Death Dis; 2019 Aug; 10(8):609. PubMed ID: 31406198 [TBL] [Abstract][Full Text] [Related]
45. Checkpoint kinase inhibitor AZD7762 overcomes cisplatin resistance in clear cell carcinoma of the ovary. Itamochi H; Nishimura M; Oumi N; Kato M; Oishi T; Shimada M; Sato S; Naniwa J; Sato S; Kudoh A; Kigawa J; Harada T Int J Gynecol Cancer; 2014 Jan; 24(1):61-9. PubMed ID: 24362713 [TBL] [Abstract][Full Text] [Related]
46. Novel therapeutic strategy targeting the Hedgehog signalling and mTOR pathways in biliary tract cancer. Zuo M; Rashid A; Churi C; Vauthey JN; Chang P; Li Y; Hung MC; Li D; Javle M Br J Cancer; 2015 Mar; 112(6):1042-51. PubMed ID: 25742482 [TBL] [Abstract][Full Text] [Related]
47. Mammalian target of rapamycin regulates isoliquiritigenin-induced autophagic and apoptotic cell death in adenoid cystic carcinoma cells. Chen G; Hu X; Zhang W; Xu N; Wang FQ; Jia J; Zhang WF; Sun ZJ; Zhao YF Apoptosis; 2012 Jan; 17(1):90-101. PubMed ID: 21956714 [TBL] [Abstract][Full Text] [Related]
48. VS-5584, a Novel PI3K-mTOR Dual Inhibitor, Inhibits Melanoma Cell Growth In Vitro and In Vivo. Shao Z; Bao Q; Jiang F; Qian H; Fang Q; Hu X PLoS One; 2015; 10(7):e0132655. PubMed ID: 26204252 [TBL] [Abstract][Full Text] [Related]
49. N-Hydroxyphthalimide exhibits antitumor activity by suppressing mTOR signaling pathway in BT-20 and LoVo cells. Wang M; Zhou A; An T; Kong L; Yu C; Liu J; Xia C; Zhou H; Li Y J Exp Clin Cancer Res; 2016 Mar; 35():41. PubMed ID: 26940018 [TBL] [Abstract][Full Text] [Related]
50. Melatonin synergistically enhances cisplatin-induced apoptosis via the dephosphorylation of ERK/p90 ribosomal S6 kinase/heat shock protein 27 in SK-OV-3 cells. Kim JH; Jeong SJ; Kim B; Yun SM; Choi DY; Kim SH J Pineal Res; 2012 Mar; 52(2):244-52. PubMed ID: 22050627 [TBL] [Abstract][Full Text] [Related]
51. [The effects of genistein on epidermal growth factor receptor mediated signal transduction pathway in human ovarian carcinoma cells lines SKOV3 and its xenograft in nude mice]. Li Y; Mi C; Wu YZ; Yang SF; Yang ZQ Zhonghua Bing Li Xue Za Zhi; 2004 Dec; 33(6):546-9. PubMed ID: 15634453 [TBL] [Abstract][Full Text] [Related]
52. The role of mTOR during cisplatin treatment in an in vitro and ex vivo model of cervical cancer. Leisching GR; Loos B; Botha MH; Engelbrecht AM Toxicology; 2015 Sep; 335():72-8. PubMed ID: 26201060 [TBL] [Abstract][Full Text] [Related]
53. Resveratrol inhibits the proliferation and induces the apoptosis in ovarian cancer cells via inhibiting glycolysis and targeting AMPK/mTOR signaling pathway. Liu Y; Tong L; Luo Y; Li X; Chen G; Wang Y J Cell Biochem; 2018 Jul; 119(7):6162-6172. PubMed ID: 29663499 [TBL] [Abstract][Full Text] [Related]
54. Synergistic effect of targeting mTOR by rapamycin and depleting ATP by inhibition of glycolysis in lymphoma and leukemia cells. Xu RH; Pelicano H; Zhang H; Giles FJ; Keating MJ; Huang P Leukemia; 2005 Dec; 19(12):2153-8. PubMed ID: 16193082 [TBL] [Abstract][Full Text] [Related]
55. Oxaliplatin-rapamycin combination was superior to mono-drug in treatment of hepatocellular carcinoma both in vitro and in vivo. Li XZ; Sun YL; Cao LQ; Li MJ Neoplasma; 2016; 63(6):880-887. PubMed ID: 27565326 [TBL] [Abstract][Full Text] [Related]
56. Combination of rapamycin and garlic-derived S-allylmercaptocysteine induces colon cancer cell apoptosis and suppresses tumor growth in xenograft nude mice through autophagy/p62/Nrf2 pathway. Li S; Yang G; Zhu X; Cheng L; Sun Y; Zhao Z Oncol Rep; 2017 Sep; 38(3):1637-1644. PubMed ID: 28737825 [TBL] [Abstract][Full Text] [Related]
57. Acetylcholinesterase expression mediated by c-Jun-NH2-terminal kinase pathway during anticancer drug-induced apoptosis. Deng R; Li W; Guan Z; Zhou JM; Wang Y; Mei YP; Li MT; Feng GK; Huang W; Liu ZC; Han Y; Zeng YX; Zhu XF Oncogene; 2006 Nov; 25(53):7070-7. PubMed ID: 16715131 [TBL] [Abstract][Full Text] [Related]
58. Targeting Mcl-1 for multiple myeloma (MM) therapy: drug-induced generation of Mcl-1 fragment Mcl-1(128-350) triggers MM cell death via c-Jun upregulation. Fan F; Tonon G; Bashari MH; Vallet S; Antonini E; Goldschmidt H; Schulze-Bergkamen H; Opferman JT; Sattler M; Anderson KC; Jäger D; Podar K Cancer Lett; 2014 Feb; 343(2):286-94. PubMed ID: 24120758 [TBL] [Abstract][Full Text] [Related]
59. Adrenergic Stimulation of DUSP1 Impairs Chemotherapy Response in Ovarian Cancer. Kang Y; Nagaraja AS; Armaiz-Pena GN; Dorniak PL; Hu W; Rupaimoole R; Liu T; Gharpure KM; Previs RA; Hansen JM; Rodriguez-Aguayo C; Ivan C; Ram P; Sehgal V; Lopez-Berestein G; Lutgendorf SK; Cole SW; Sood AK Clin Cancer Res; 2016 Apr; 22(7):1713-24. PubMed ID: 26581245 [TBL] [Abstract][Full Text] [Related]
60. RAD001 inhibits human ovarian cancer cell proliferation, enhances cisplatin-induced apoptosis, and prolongs survival in an ovarian cancer model. Mabuchi S; Altomare DA; Cheung M; Zhang L; Poulikakos PI; Hensley HH; Schilder RJ; Ozols RF; Testa JR Clin Cancer Res; 2007 Jul; 13(14):4261-70. PubMed ID: 17634556 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]